OCC
ORTHOCELL LIMITED
$0.7450
▲ +0.68%
Market cap
$203M
Turnover
$326,813
Last price
$0.7450
Day change
+0.68%
Announcements
8
Range, past year
Open 1.245 · Low 0.670 · Now 0.745 · High 1.700
Open OCC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
OCC momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
26/100
Wyckoff phase
Accumulation3d
Trend stage
Emerging
1 Day
+0.7%
1 Week
+1.4%
1 Month
-1.3%
1 Year
-42.7%
RSI
52
Avg daily range
4.7%
ORTHOCELL LIMITED scores 26 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Accumulation, where it has been for 3 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -20.7%
- Risk rating: High
- Composite downside risk elevated
OCC announcements
Recent price-sensitive releases.
- 2026-09-21 Orthocell Achieves First Remplir Sales in Thailand Progress Report
- 2026-08-31 Appendix 4E & Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-14 Q4 FY26 ASX Investor Presentation
- 2026-07-13 Quarterly Activity Report & Appendix 4C
- 2026-07-03 Orthocell Appoints Thailand Distributor for Remplir
- 2026-04-30 First Sales of Remplir Achieved in US$75m Canadian Market
- 2026-04-28 Compelling 90% Success Rate for Remplir in Real World Study
More Health Care stocks
Most traded in the same sector.